Orion Biotech Opportunities Corp. Units
ORIAU
ORIAU was delisted on the 25th of April, 2023.
21 hedge funds and large institutions have $73.8M invested in Orion Biotech Opportunities Corp. Units in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 23 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
45% less capital invested
Capital invested by funds: $134M → $73.8M (-$60.2M)
51% less funds holding
Funds holding: 43 → 21 (-22)
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
+$400K |
| 2 |
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
|
+$299K |
| 3 |
CCM
Context Capital Management
Lajolla,
California
|
+$57.9K |
| 4 |
WC
Wealthspring Capital
West Harrison,
New York
|
+$40K |
| 5 |
Jane Street
New York
|
+$629 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$10.1M |
| 2 |
SCC
Spring Creek Capital
Wichita,
Kansas
|
-$8.04M |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$6.03M |
| 4 |
ACM
Atalaya Capital Management
New York
|
-$5.03M |
| 5 |
FIG
Fortress Investment Group
New York
|
-$4.31M |
ORIAU Hedge Fund Activity: Q3 2021 in Review
21 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Units (ORIAU) for Q3 2021, worth a combined $73.8M — down 45% from $134M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of ORIAU and 1 opened new positions — a net loss of 22 holders — while 7 trimmed existing stakes and 4 added.
The largest buyer was OMERS Administration Corp, opening a new position worth an estimated $400K. The largest seller was Fir Tree Capital Management, exiting entirely with an estimated $10.1M sold.
- 21 institutional investors held Orion Biotech Opportunities Corp. Units (ORIAU) as of Q3 2021, down from 43 in Q2 2021.
- Funds reported $73.8M of Orion Biotech Opportunities Corp. Units stock for Q3 2021, down 45% quarter-over-quarter.
- 1 fund opened new Orion Biotech Opportunities Corp. Units positions in Q3 2021 and 23 closed out, a net change of -22 holders.
- The largest Orion Biotech Opportunities Corp. Units buyer in Q3 2021 was OMERS Administration Corp, an estimated $400K added.
- The largest Orion Biotech Opportunities Corp. Units seller in Q3 2021 was Fir Tree Capital Management, an estimated $10.1M sold.
Based on aggregated 13F filings for Q3 2021.